Portfolio Lab

Amn Healthcare Services Inc

  • Stock
  • Ticker AMN
  • ISIN US0017441017
  • NYSE

Industrials · Business services · USA

$35.68 +3.87%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Amn Healthcare Services Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

AMNGlobal equities (VT)

$10,000 grew to $10,667. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −88.1% in 01/2026, measured from the peak in 11/2022. The old peak has not been reached again yet.

1-year return
+132.6%
5-year return p.a.
−21.4%
10-year return p.a.
+0.6%
Volatility p.a.
44.1%
Largest decline
−88.1%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue7356906586347481,378673717
Gross profit219198196184195369206229
Operating income-20313-124488.11172751
EBITDA-16152-8685451535880
Net income-188-1.1-11629-7.7622133
Earnings per share-4.91-0.03-3.020.76-0.191.590.530.83
Balance sheet
Total assets2,4162,3952,2122,1392,0942,6042,3642,293
Liabilities1,7091,6801,6051,4951,4521,8921,6231,518
Equity707715608644642713741775
Cash1156425334561362256
Long-term debt1,056–––767–––
Cash flow
Operating cash flow7393792376562-190-88
Capital expenditure-16-10.0-9.8-7.9-7.9-7.2-8.5-9.8
Free cash flow5783691568555-198-97

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2021 at +79.2%, weakest 2024 at −68.1%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
6 Nov 2026$0.83
7 Aug 2026$0.53
8 May 2026$1.59
20 Feb 2026−$0.19
7 Nov 2025$0.76
8 Aug 2025−$3.02
9 May 2025−$0.03
21 Feb 2025−$4.91
8 Nov 2024$0.18
9 Aug 2024$0.42
10 May 2024$0.45
22 Feb 2024$0.37

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€1.2bn
Market cap in trading currency
$1.38bn
Enterprise value
$1.12bn
P/E
12.9
P/S
0.39
P/B
1.78
EV/Sales
0.32
EV/EBITDA
3.3
Earnings yield
7.7%
FCF yield
23.8%

Results (last four quarters)

Revenue
$3.52bn
Gross profit
$999m
EBITDA
$337m
Net income
$109m
Earnings per share
$2.76
Revenue per share
$91.20
Revenue growth
+13.0%
Earnings growth
+14.0%

Profitability

Gross margin
28.4%
Operating margin
5.8%
Net margin
3.1%
Return on equity
15.4%
Return on assets
4.8%

Balance sheet and cash flow

Cash
$256m
Cash per share
$6.64
Financial debt
–
Debt/equity %
–
Current ratio
1.21
Book value per share
$20.10
Operating cash flow
$361m
Free cash flow
$327m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
38.6m
Volume
817,959
Avg. volume 3 months
753,678
Relative volume
1.1

Price and technicals

Price
$35.68
1 day
+3.9%
52-week high
$49.00
52-week low
$15.10
Distance to 52-week high
−27.2%
Distance to 52-week low
+136.3%
Distance to 50-day line
−8.4%
Distance to 200-day line
+19.2%
RSI (14)
39
Volatility 1M
107.5%

Performance

1 week
−6.2%
1 month
−23.8%
3 months
+3.4%
6 months
+29.0%
YTD
+126.4%
1 year
+126.1%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has AMN performed since 11/2016?

$10,000 grew to $10,667 by 20 Nov 2026, which is +0.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is AMN?

Volatility was 44.1% per year, measured on monthly returns. The largest decline from a peak was −88.1%, with the low in 01/2026.

How does AMN compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, AMN returned +0.6% at 44.1%. The correlation of monthly returns was 0.18; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Amn Healthcare Services Inc (AMN): Return and risk